{"id":19262,"date":"2019-05-13T18:07:15","date_gmt":"2019-05-14T02:07:15","guid":{"rendered":"https:\/\/associatednews.info\/content\/california-jury-awards-2-billion-to-couple-in-roundup-weed-killer-cancer-trial\/"},"modified":"2019-05-13T18:07:15","modified_gmt":"2019-05-14T02:07:15","slug":"california-jury-awards-2-billion-to-couple-in-roundup-weed-killer-cancer-trial","status":"publish","type":"post","link":"https:\/\/associatednews.info\/content\/california-jury-awards-2-billion-to-couple-in-roundup-weed-killer-cancer-trial\/","title":{"rendered":"California Jury Awards $2 Billion To Couple In Roundup Weed Killer Cancer Trial"},"content":{"rendered":"

By Richard Gonzales<\/a><\/span> <\/p>\n

<\/p>\n
\n <\/a><\/div>\n
\n
\n
\n Enlarge this image<\/a>\n <\/div>\n<\/div>\n
\n
\n
\n

\n Containers of Roundup are displayed on a store shelf in San Francisco. A third California jury has awarded a multimillion-dollar court judgment against the herbicide.<\/p>\n

<\/p>\n

Haven Daley\/AP<\/p>\n

<\/b>
\n hide caption<\/b><\/b>\n <\/p>\n<\/p><\/div>\n

toggle caption<\/b><\/b>\n <\/div>\n

<\/p>\n

Haven Daley\/AP<\/p>\n

<\/span>\n<\/div>\n<\/p><\/div>\n

A California jury has awarded a couple more than $2 billion in a verdict against Monsanto, a subsidiary of Bayer. This is the third recent court decision involving claims that the company’s Roundup weed killer caused cancer.<\/p>\n

The jury in Alameda County, just east of San Francisco, ruled that the couple, Alva and Alberta Pilliod of Livermore, California, contracted non-Hodgkins lymphoma due to their use of the glyphosate-based herbicide. They were each awarded $1 billion in punitive damages and an additional $55 million in collective compensatory damages.<\/p>\n

Many legal experts believe the damages will be drastically reduced on appeal.<\/p>\n

The verdict represents the third such legal setback for the company in California since mid-2018. In March, a San Francisco jury awarded a man $80 million<\/a> who blamed his cancer on his extensive use of Roundup. In August 2018, another San Francisco jury awarded $289 million to a fourth plaintiff. On appeal a judge later slashed that payout to $78 million<\/a>. Bayer is appealing each of these verdicts. And the company insists there is no link between Roundup and non-Hodgkins’s lymphoma.<\/p>\n